Clinical Trials Logo

Clinical Trial Summary

The purpose of this research is evaluate the results with laparoscopic ALPPS procedure in a single center. The validity, feasibility and limitations were assessed objectively through our clinical prospective study.The investigators expect laparoscopic ALPPS is safe, effective and feasible.


Clinical Trial Description

Background: Associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) is a breakthrough in the field of hepatobiliary surgery in recent years,which stimulates the remnant liver volume(RLV) grew by 74%-87.2% in 9 to 13 days。The published literature reported that the two stages of ALPPS are the conventional laparotomy surgery,Patients need to undergo the injury of two open operations in a short time. The incidence of postoperative complications and mortality rate is as high as 53% -73% and 12%-27%.The aim of this study was to evaluate the results with laparoscopic ALPPS procedure in a single center, with special emphasis in validity, feasibility and limitations. Results: Clinical data include: operation time, intraoperative blood loss, volume of blood transfusion, complications and mortality, postoperative liver function, long-term curative effect and survival time were collected and analysed. Statistical method:groups t-test ,univariate/multivariate analysis, logistic regression analysis, mixed linear regression, Cox survival analysis ,Kaplan-Meier survival analysis,Log-rank survival curves were used. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT02203409
Study type Observational
Source Southwest Hospital, China
Contact Shuguo Zheng
Phone 86-13508308676
Email shuguozh@gmail.com
Status Recruiting
Phase
Start date July 2014
Completion date August 2022

See also
  Status Clinical Trial Phase
Completed NCT04241887 - Is Thoracic Paravertebral Block a Better Option Than Conscious Sedation for PRFA of Liver Tumors N/A
Recruiting NCT04274868 - Pediatric Hepatic Tumors
Completed NCT02985034 - Safety Margin Assessment After RFA Using the Registration of Pre-ablation MRI and Post-ablation CT N/A
Completed NCT02424955 - Feasibility 3D Perfusion Ultrasound for Liver Cancer SABR Planning and Response Evaluation N/A
Recruiting NCT05555316 - TACE Combined With Lenvatinib and MWA in the Treatment of Locally Advanced Large Hepatocellular Carcinoma Phase 2
Recruiting NCT03579199 - Practical Application of Indocyanine Green Camera in Laparoscopic Liver Surgery N/A
Completed NCT02958592 - Assessment of Hepatic Fibrosis by Shear Wave Elastography in Patients With Liver Malignancy: A Prospective Single-center Study N/A
Completed NCT05370001 - Endotracheal Tube Size Effect on the Carbon Dioxide Washout During Jet Ventilation N/A
Enrolling by invitation NCT03739164 - Tampa Associating Microwave Liver Ablation With Portal Vein Ligation for Staged Hepatectomy (TAMLAPS)
Recruiting NCT05211388 - Treat-and-resect Study of Echo Decorrelation Imaging-controlled Radiofrequency Ablation in Liver Tumors N/A
Recruiting NCT05516394 - National Polish Registry of Minimally Invasive Liver Surgery
Completed NCT02849015 - Combination of Cryosurgery and NK Immunotherapy for Tumors in Transplanted Liver Phase 1/Phase 2
Completed NCT02018107 - PET/CT-Assessment of Liver Tumor Ablation N/A
Recruiting NCT01677728 - Effect of Target Therapy on Patients Undergoing Synchronic Hepatectomy for Colorectal Liver Metastases N/A
Recruiting NCT06060899 - Intraoperative Blood Loss Under Standard Versus Low Pneumoperitoneum Pressure During Laparoscopic Liver Resection. N/A
Completed NCT03783871 - NeuWave HCC China Study N/A
Enrolling by invitation NCT01812577 - Paravertebral Block for Percutaneous Radiofrequency Ablation of Liver Lesions
Not yet recruiting NCT05161624 - Accuracy Evaluation of Artificial Intelligence Assisted Liver Tumor Ablation Path Planning
Completed NCT02226666 - Physiologic Assessment Following Gadoxetic Acid and Gadobenate Dimeglumine Administration N/A
Recruiting NCT04812054 - Dual Hypothermic Oxygenated Machine Perfusion in Liver Transplantation Using Allografts From Donors After Brain Death N/A